In December 2025, CVS Health raised its 2025 guidance to at least US$400.0 billion in revenue and higher GAAP operating income, while also forecasting a US$5.73 billion goodwill impairment. At the ...

Television brings you the latest news and analysis leading up to the final minutes and seconds before and after the closing ...

BlackRock, the world's largest asset manager, ran an online survey in early December asking respondents whether attractive ...

Retail pharmacy chain CVS Health’s ($CVS) shares are up 81.86% year-to-date despite subsidiary Omnicare’s recent Texas ...

CVS Health (CVS) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some ...

Below are the ratings of the most accurate analysts for three high-yielding stocks in the health care sector. Canaccord Genuity analyst Susan Anderson maintained a Buy rating and cut the price target ...

Are health insurance stocks like UnitedHealth, CVS, and Oscar a buy, sell, or hold right now? Seeking Alpha analysts weigh in ...

Citing topline data from its Phase 3 TRIUMPH-4, the Indiana-based drugmaker said that retatrutide, a GIP, GLP-1, and glucagon triple hormone receptor agonist, at the two highest doses led to ...

These companies could innovate their way to success.

As Molina Healthcare has lagged behind the Dow over the past year, analysts remain cautious about the stock’s prospects.

Truist Financial analyst David S Macdonald reiterated a Buy rating on CVS Health today and set a price target of $98.00. According to TipRanks, S Macdonald is a 5-star analyst with an average return ...

According to TipRanks.com, Wright is a 5-star analyst with an average return of 14.3% and a 65.5% success rate. Wright covers the Healthcare sector, focusing on stocks such as BrightSpring Health ...